American Funds International Vantage Fund Class R-1 (RIVAX) dividend summary: yield, payout, growth, announce date, ex-dividend date, payout date and Seeking Alpha Premium dividend score.

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is advancing its phase 3 replication study (“FLASH2”) for HyBryte(TM), a novel photodynamic therapy designed to treat early ...

RIVAX - American Funds International Vntg R-1 - Review the RIVAX stock price, ... USD | NAV as of May 09, 2025 | 1-Day Return as of May 09, 2025, 10:20 PM GMT+0. Morningstar’s Analysis RIVAX.

View Historical Risk Statistics for American Funds International Vntg R-1 (RIVAX).

Get the latest American Funds International Vntg R-1 (RIVAX) stock news and headlines to help you in your trading and investment decisions.

December 20, 2022 — 08:17 am ... RiVax has received Orphan Drug and Fast Track designations from the FDA, and, upon approval, has the potential to qualify for a biodefense Priority Review ...

PRINCETON, N.J., Dec. 20, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products ...